cagrilintide: Clinical Trials

3 trials of cagrilintide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow cagrilintide: new trials by email Literature Review of cagrilintide trials Research Report on cagrilintide

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
NNC0194-0499, Semaglutide, NNC0194-0499 placebo - Alcohol-related Liver Disease
Phase 2CompletedNovo Nordisk A/S2702024-05-202026-03-12
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
Cagrilintide, Semaglutide, Placebo - Chronic Kidney Disease, Type 2 Diabetes
Phase 2CompletedNovo Nordisk A/S6262024-04-012026-09-24
Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes
Semaglutide 2.4 mg, Cagrilintide 2.4 mg, Placebo (semaglutide) - Diabetes Mellitus, Type 2
Phase 2CompletedNovo Nordisk A/S922021-08-022025-12-23

Conditions studied

Diabetes Mellitus, Type 2 (2)  ·  Obesity (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Novo Nordisk A/S (3)

Countries

United States (3)  ·  Canada (2)  ·  France (2)  ·  Greece (2)  ·  Japan (2)  ·  Poland (2)  ·  Spain (2)  ·  Argentina (1)  ·  Australia (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Germany (1)  ·  Hungary (1)

NIH funding

2023 (2)